Session #1 – First On The Scene
Saturday October 22, 2022 – 8:30am – 10:45am
Session #2 – Oral/Oropharyngeal Cancer Screening: What’s New? What’s Changed?
Saturday October 22, 2022 – 11:00am – 12:30pm
Outline: Session #1 First On The Scene
By definition a first responder is “a person with specialized training who is among the first to arrive and provide assistance at the scene”. The dental hygienist is a ‘first responder’ to the oral cavity with our profession being optimally situated at the portal of entry and the gateway to systemic health. The oral-systemic link conceptually is not new, however the reduction of the burden of chronic inflammation has become a benchmark of healthcare delivery. The presentation integrates an opportunity for attendees to self-evaluate their assessment protocols as they relate to risk intervention complemented by educational resources for clinical practice and client education. Our actions and assessment as a critical stakeholder dictate treatment outcomes, and strongly influence both the quality and quantity of life of every client seated in our treatment room.
Outline: Session #2 Oral/Oropharyngeal Cancer Screening: What’s New? What’s Changed?
As a dental professional, we are ideally situated to make a direct impact on earlier discovery, better treatment outcomes and increased survival rates related to oral and oropharyngeal cancer. Unfortunately, incidence rates continue to rise each year and we are simply not making the successful inroads with oral/oropharyngeal cancer as we are with so many other cancers. Historically the vulnerable populations were those who used tobacco and alcohol. This is no longer the case.
We are living in a VIRAL world with the fastest growing segment of oropharyngeal cancers, being attributed to a very common virus. How does this impact our screening practices to meet the needs of today’s population? What are the implications to dentistry and how should our oral cancer screening be adjusted to compensate for this new profile? How is the virus transmitted and once an infection becomes active, will it ever go away? How does an infection transform into a malignancy? Who is at risk? A recent ‘call to action’ by the Chief Dental Officer of Canada to dental professionals to play a significant role in raising awareness, educating, counselling and promoting evidence-based risk intervention strategies underlies the critical necessity for change in our screening practices.
Upon completion of the presentation, the participant will be able to;
CDHBC QAP Competency – TBD
Ms. Jo-Anne Jones, RDH
Ms. Jo-Anne Jones, RDH – As an international, award-winning speaker, Jo-Anne Jones has done over 1,000 presentations across the U.S., Canada, and Europe. Jo-Anne brings life, energy, inspiration and a dynamic speaking style that has made her a sought-after lecturer in the dental community. Jo-Anne joins the 2022 Dentistry Today CE Leaders for the 12th consecutive year and is a 2021 Fellowship Award recipient with the International Academy of Dental Facial Esthetics.
In the midst of preparing to present her extensive research on HPV-related oropharyngeal cancer to her national association, Jo-Anne’s family were dealt a crushing blow of having a family member diagnosed with late-stage HPV-positive tonsillar cancer. Jo-Anne proudly partners with the Oral Cancer Foundation in conveying the urgent need for change in the way we screen for oral and oropharyngeal cancer. Jo-Anne was instrumental in launching the international ‘Check Your Mouth’ campaign promoting oral self-examination between professional visits.